Powder: -20°C for 3 years | In solvent: -80°C for 2 years
Latrepirdine is an orally active, and neuroactive antagonist of multiple drug targets, including histamine receptors, GluR, and 5-HT receptors, used as an antihistamine drug.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 5 days | $ 43.00 | |
10 mg | 5 days | $ 86.00 | |
1 mL * 10 mM (in DMSO) | 5 days | $ 48.00 |
Description | Latrepirdine is an orally active, and neuroactive antagonist of multiple drug targets, including histamine receptors, GluR, and 5-HT receptors, used as an antihistamine drug. |
In vitro | Latrepirdine increases succinate dehydrogenase activity (MTT-assay), mitochondrial membrane potential (DeltaPsim), and cellular ATP levels in primary mouse cortical neurons and human neuroblastoma cells (SH-SY5Y). Latrepirdine enhances mitochondrial function both in the absence and presence of stress and Dimebon-treated cells are partially protected to maintain cell viability. [1] Latrepirdine leads to enhanced mTOR- and Atg5-dependent autophagy in cultured mammalian cells. [2] latrepirdine stimulates MTOR- and ATG5-dependent autophagy, leading to the reduction of intracellular levels of APP metabolites, including Aβ in cultured cells. [3] Latrepirdine stimulates the degradation of α-syn in differentiated SH-SY5Y neurons, and in mouse brain following chronic administration, in parallel with elevation of the levels of markers of autophagic activity. [4] Latrepirdine increases intracellular ATP levels and glucose transporter 3 translocation to the plasma membrane in primary neuron. [5] |
In vivo | Latrepirdine treatment of TgCRND8 transgenic mice is associated with improved learning behavior and with a reduction in accumulation of Aβ42 and α-synuclein. [2] Latrepirdine administration results in increased levels of the biomarkers thought to correlate with autophagy activation in the brains of TgCRND8 (APP K670M, N671L, V717F) or wild-type mice, and that treatment is associated with abrogation of behavioral deficit, reduction in Aβ neuropathology, and prevention of autophagic failure among TgCRND8 mice. [3] |
Synonyms | Dimebolin, Latrepirdine 2HCl, Dimebolin dihydrochloride, Latrepirdine |
Molecular Weight | 392.37 |
Formula | C21H25N3·2HCl |
CAS No. | 97657-92-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
DMSO: 39.2 mg/mL (100 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Latrepirdine dihydrochloride 97657-92-6 Autophagy GPCR/G Protein Immunology/Inflammation Neuroscience 5-HT Receptor Beta Amyloid Adrenergic Receptor GluR Histamine Receptor Serotonin Receptor Dimebolin 5-hydroxytryptamine Receptor Latrepirdine 2HCl Amyloid-β Inhibitor Dimebolin dihydrochloride inhibit Abeta β-amyloid peptide Latrepirdine Beta Receptor inhibitor